News | May 08, 2022
Quality issues force Novartis to suspend production of radioligand therapy medicines
The production suspension impacts commercial and clinical trial supply
The production suspension impacts commercial and clinical trial supply
Upon closing, the Quakertown business will become an independent company called Microsize
Evonik in association with Remondis has opened its first plant in India to ensure Zero Liquid Discharge. It is located at Dombivli in Western Maharashtra
Flagship U.S. facility will include biologic manufacturing and late stage research and clinical development of innovative cancer medicines
The new lab in the industrial town is SRL’s 4th lab in the state of Jharkhand
The $44 million facility is part of Thermo Fisher's $650 million multi-year investment, announced last year, to help ensure flexible, scalable and reliable bioprocessing production capacity exists for critical materials used in developing new and existing biologics and vaccines, including for COVID-19
Company has invested $150 million to build a 150,000 square-foot commercial manufacturing facility in Research Triangle Park (RTP), North Carolina
Ideal power boosters to strengthen muscles and keep energised for all kinds of physical activities
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
Global event to kick off as the post-covid era begins in earnest, with theme "beyond the pandemic, into a next wave"
Subscribe To Our Newsletter & Stay Updated
